You are Here: Drug Litigation

Drug Litigation: A Brief Overview:

From time to time, pharmaceutical drugs with dangerous and sometimes deadly side effects enter the marketplace because their potential risks were not properly anticipated during clinical research trials. These types of drugs are closely monitored by the FDA (Food & Drug Administration), a governmental agency charged with protecting the public welfare with respect to food and drug products that are made available to consumers.

The FDA accomplishes this charge in a variety of ways, including, but not limited to, issuing alerts about certain drugs, mandating the publication of warnings with regards to certain drugs, and in some instances, initiating full recalls of certain drugs. Whatever action the FDA deems necessary, it does not change the fact that these types of drugs often times cause harm and/or injury to the individuals who took them, and when these individuals look to be made whole for the damages they have suffered, litigation often emerges as a primary course of action for most victims. If you or someone you know has been injured by a drug, the attorneys at Sullo & Sullo can help – please let us know about your case.


Drug Litigation: Claims & Lawsuits:

Shown below are drugs which may have resulted in harm and/or injuries to the individuals who took them. Read more to find out if you or someone you know may have been affected:

Actos Brief Overview:

Actos (pioglitazone hydrochloride) is a member of a class of drugs known as thiazoli-dinediones, which have been linked to liver and cardiovascular issues.  More...


Pradaxa Brief Overview:

For those patients with heart valve problems or atrial fibrillation who are at a significantly elevated risk of stroke, the drug Pradaxa (Dabigatran)...  More...


Topamax Brief Overview:

On May 21, 2010, officials from Ortho-McNeil Pharmaceuticals, a subsidiary of Johnson & Johnson, pled guilty to criminal charges related to the...  More...


Depakote Brief Overview:

Depakote, an Abbott Laboratories drug, was approved for use in 1983 by the U.S. Food and Drug Administration. Since that time, it has primarily been ...  More...


Januvia Issues:

Januvia, a drug which is used in the treatment of type 2 diabetes—along with diet and exercise—has recently come under fire for its potential risks from consumers ...  More...


Byetta Issues:

Exenatide, the drug marketed under the name Byetta, was originally manufactured by Amylin Pharmaceuticals in collaboration with ...  More...


Victoza Issues:

A nonprofit consumer advocacy group, Public Citizen, claims Victoza, a drug manufactured for the treatment of type-2 diabetes, gained FDA approval ...  More...


How We Can Help:

As a qualified products liability law firm, Sullo & Sullo is able to help you in several very important ways: More...


Free Consultation  Call Now

Get Interactive

 
 
Free Consultation
Receive an immediate response to your request.
Choose practice area of your problem:

I understand and agree that submitting this form does not create an attorney-client relationship and that the information I submit is not confidential or privileged and may be shared. I further understand and agree to the Terms of Use and Privacy Policy

CAPTCHA image
Enter the code shown above in the box below

Recent Articles & Publications

May 17, 2012
FDA Approves Cancer Warning for Diabetic Drug Actos
The blockbuster drug, Actos, which is prescribed to control Type 2 diabetes, has received new warning language on the label regarding a potential risk of bladder cancer for those taking the drug. Actos, also known as pioglitazone, is manufactured by Takeda Pharmaceuticals, a Japanese-based company, and is currently their best-selling drug, with sales of $3.4 billion last year alone.

May 15, 2012
Actos® Adverse Effects
Many of us would be very surprised to find that a drug can be approved by the FDA yet still have serious—and undisclosed—side effects. The drug Actos, used in the treatment of Type 2 diabetes, is one such drug. Actos works by decreasing the body’s resistance to insulin as a way of controlling blood sugar levels. Actos is currently being used by millions of people across the globe, with sales jumping from around $2.9 billion in 2006 to over $4.3 billion in 2010.

April 24, 2012
Recovering From Actos-Related Bladder Cancer: Part 1of 2: How Can I Prevent a Recurrence?
Actos, or pioglitazone, is a prescription medicine used in the treatment of Type-2 diabetes and works by sensitizing cells to the pancreas-produced hormone known as insulin. Insulin is used by the body to regulate the amount of sugar or glucose in the body therefore when cells are more sensitive to insulin, sugar in the blood naturally moves more easily into cells.